IN2015KN00516A - - Google Patents

Info

Publication number
IN2015KN00516A
IN2015KN00516A IN516KON2015A IN2015KN00516A IN 2015KN00516 A IN2015KN00516 A IN 2015KN00516A IN 516KON2015 A IN516KON2015 A IN 516KON2015A IN 2015KN00516 A IN2015KN00516 A IN 2015KN00516A
Authority
IN
India
Prior art keywords
ty21a
vaccines
recombineered
recombineering
compositions
Prior art date
Application number
Other languages
English (en)
Inventor
Madushini Nirosha Dharmasena
Dennis J Kopecko
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Publication of IN2015KN00516A publication Critical patent/IN2015KN00516A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/25—Shigella (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN516KON2015 2012-09-17 2013-09-16 IN2015KN00516A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261701939P 2012-09-17 2012-09-17
PCT/US2013/059980 WO2014043637A1 (fr) 2012-09-17 2013-09-16 Vaccin oral multifonctionnel sur la base de la recombinaison homologue chromosomique

Publications (1)

Publication Number Publication Date
IN2015KN00516A true IN2015KN00516A (fr) 2015-07-17

Family

ID=50278754

Family Applications (1)

Application Number Title Priority Date Filing Date
IN516KON2015 IN2015KN00516A (fr) 2012-09-17 2013-09-16

Country Status (9)

Country Link
US (1) US9750793B2 (fr)
EP (1) EP2895596A4 (fr)
JP (1) JP2015533491A (fr)
KR (1) KR20150058435A (fr)
CN (1) CN104812890A (fr)
HK (1) HK1211980A1 (fr)
IL (1) IL237339B (fr)
IN (1) IN2015KN00516A (fr)
WO (1) WO2014043637A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2988762T3 (pl) * 2013-04-25 2019-01-31 Vaximm Ag Wektory na bazie Salmonella do immunoterapii przeciwnowotworowej ukierunkowanej na gen guza Wilmsa WT1
DK3082850T3 (da) 2013-12-18 2019-10-07 Vaximm Gmbh Msln-targeteret dna-vaccine til cancerimmunterapi
CN105734001B (zh) * 2014-12-08 2020-04-07 中国人民解放军军事医学科学院生物工程研究所 一种o抗原糖链延长的甲型副伤寒沙门氏菌及其应用
IL256729B2 (en) * 2015-07-06 2023-03-01 Protein Potential Llc Live attenuated vaccine for oral administration against shigellosis and typhoid fever
CN106801029B (zh) * 2017-01-22 2020-05-01 山东大学 一株重组大肠杆菌及其在制备抗志贺氏菌的糖疫苗中的应用
MY190074A (en) * 2018-01-09 2022-03-24 Aimst Univ A monovalent vaccine formulation and a method for preparation thereof
US20220098599A1 (en) 2019-02-06 2022-03-31 Fred Hutchinson Cancer Research Center Minicircle producing bacteria engineered to differentially methylate nucleic acid molecules therein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7541043B2 (en) * 2002-01-16 2009-06-02 The United States Of America As Represented By The Department Of Health And Human Services Vaccine for protection against Shigella sonnei disease
WO2005116063A1 (fr) 2004-05-24 2005-12-08 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Vaccin oral vivant destine a la protection contre le serotype i de shigella dysenteriae

Also Published As

Publication number Publication date
KR20150058435A (ko) 2015-05-28
US9750793B2 (en) 2017-09-05
HK1211980A1 (en) 2016-06-03
WO2014043637A1 (fr) 2014-03-20
EP2895596A1 (fr) 2015-07-22
EP2895596A4 (fr) 2016-07-27
IL237339B (en) 2019-06-30
US20150238591A1 (en) 2015-08-27
IL237339A0 (en) 2015-04-30
JP2015533491A (ja) 2015-11-26
CN104812890A (zh) 2015-07-29

Similar Documents

Publication Publication Date Title
HUS2200035I1 (hu) Konjugált burokszaccharid antigéneket tartalmazó immunogén készítmények és alkalmazásaik
IN2015KN00516A (fr)
MX2017001406A (es) Agentes a base de flagelina y usos de los mismos, incluyendo vacunación efectiva.
MX352324B (es) Vacunas multivalentes de nanovehiculos sinteticos.
BR112013010288A2 (pt) método de produção de uma vacina para proteger um animal de biótipo de microrganismo, vacina para proteger um animal de um biótipo de microrganismo, método para proteger um animal e método para determinar se um animal foi vacinado
HK1251250A1 (zh) 作為腸道菌群的益生基礎菌種的雙歧桿菌
EP2998322A4 (fr) Vaccin à base d'épitopes pour protéine de faible immunogénicité et son procédé de préparation et d'utilisation
EP3038619C0 (fr) Composé et méthode de vaccination et d'immunisation
MX2017002803A (es) Coronavirus bovino atenuado y vacunas relacionadas.
PH12017500304A1 (en) Vaccine compositions against dengue virus diseases
MA46661A (fr) Formulations de vaccin glycoconjugué dirigé contre expec
SG11201702037SA (en) Immunogenic/therapeutic glycoconjugate compositions and uses thereof
IL241271A (en) Al-Thai pertussis vaccine
MX2016010838A (es) Vacunas de proproteina convertasa subtilisina/kexina tipo 9 (pcsk9).
GB201801566D0 (en) Methods and compositions for nanormulsion vaccine formulations
EP3270897A4 (fr) Compositions immunogènes pour une utilisation en vaccination contre les bordetella
PH12017501795A1 (en) Pestivirus vaccines for congenital tremors
HUE047361T2 (hu) Javított intracelluláris energia-szintû mikroorganizmus és L-aminosav elõállítására szolgáló eljárás annak alkalmazásával
HK1255555A1 (zh) 抗志賀氏菌病和傷寒的活性減毒口服疫苗
EA201690378A1 (ru) Вакцинные композиции против наркотической зависимости
EP3538197A4 (fr) Dispositifs et procédés d'amélioration de l'immunogénicité vis-à-vis d'une vaccination intradermique
TWI563085B (en) Dendritic cell tumor vaccine and preparation method thereof
EP3137111A4 (fr) Compositions et méthodes d'administration de vaccins intradermiques
BR112015009300A2 (pt) método de produção de uma vacina para proteger um animal de um biotipo de um microrganismo, método de proteção de um animal de um biotipo de um microrganismo e vacina para proteger um animal de um biotipo de um microrganismo.
TH1501001330A (th) องค์ประกอบของวัคซีนเชื้อเป็นแบบผสมสำหรับป้องกันโรคสเตรปโตคอคโคซีส ในสัตว์น้ำและกรรมวิธีการผลิตองค์ประกอบของวัคซีนดังกล่าว